Cargando…
A cohort study to identify risk factors for Plasmodium falciparum infection in Burkinabe children: implications for other high burden high impact countries
BACKGROUND: Progress in controlling malaria has stalled in recent years. Today the malaria burden is increasingly concentrated in a few countries, including Burkina Faso, where malaria is not declining. A cohort study was conducted to identify risk factors for malaria infection in children in southw...
Autores principales: | Yaro, Jean Baptiste, Ouedraogo, Alphonse, Ouedraogo, Z. Amidou, Diarra, Amidou, Lankouande, Malik, Agboraw, Efundem, Worrall, Eve, Toe, Kobié Hyacinthe, Sanou, Antoine, Guelbeogo, W. Moussa, Sagnon, N’Fale, Ranson, Hilary, Tiono, Alfred B., Lindsay, Steven W., Wilson, Anne L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565747/ https://www.ncbi.nlm.nih.gov/pubmed/33066799 http://dx.doi.org/10.1186/s12936-020-03443-x |
Ejemplares similares
-
Risk factors associated with house entry of malaria vectors in an area of Burkina Faso with high, persistent malaria transmission and high insecticide resistance
por: Yaro, Jean Baptiste, et al.
Publicado: (2021) -
Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention
por: Yaro, Jean Baptiste, et al.
Publicado: (2022) -
Anopheline species composition and the 1014F-genotype in different ecological settings of Burkina Faso in relation to malaria transmission
por: Traoré, Alphonse, et al.
Publicado: (2019) -
Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
por: Sirima, Sodiomon B., et al.
Publicado: (2009) -
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
por: Bougouma, Edith Christiane, et al.
Publicado: (2022)